Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3336101 | Transfusion and Apheresis Science | 2009 | 5 Pages |
Abstract
The aim of this study was to investigate whether PMMA–CHDF in the treatment of a patient with septic acute renal failure (septic ARF) is clinically relevant. Thirteen patients were treated with PMMA–CHDF. Thirteen patients were treated with PAN–CHDF. The urinary output significantly increased in PMMA–CHDF group following 24 h of the treatment (p < 0.05), whereas those did not improve in PAN–CHDF group. The 28-day survival was 84.6% in PMMA–CHDF group and 38.5% in PAN–CHDF group, respectively (p < 0.05). We can assume that the cytokine modulation with PMMA–CHDF in the treatment of patients with septic ARF is clinically relevant.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Kenichi Matsuda, Takeshi Moriguchi, Norikazu Harii, Junko Goto,